Ann E. Haight

2.9k total citations
55 papers, 1.1k citations indexed

About

Ann E. Haight is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ann E. Haight has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 26 papers in Genetics and 23 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ann E. Haight's work include Hemoglobinopathies and Related Disorders (26 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Prenatal Screening and Diagnostics (12 papers). Ann E. Haight is often cited by papers focused on Hemoglobinopathies and Related Disorders (26 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Prenatal Screening and Diagnostics (12 papers). Ann E. Haight collaborates with scholars based in United States, Canada and Australia. Ann E. Haight's co-authors include John Horan, Kristin Stegenga, Rebecca D. Pentz, Donna A. Wall, James D. Fortenberry, Lakshmanan Krishnamurti, Robert Sheppard Nickel, Marianne E. McPherson, Sharron L. Docherty and Joan E. Haase and has published in prestigious journals such as Blood, PEDIATRICS and Cancer.

In The Last Decade

Ann E. Haight

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann E. Haight United States	19	473	375	336	181	131	55	1.1k
Johan Arvidson Sweden	20	520 1.1×	443 1.2×	325 1.0×	368 2.0×	294 2.2×	47	1.3k
Gregory M.T. Guilcher Canada	16	582 1.2×	303 0.8×	253 0.8×	197 1.1×	167 1.3×	80	983
Michael D. Amylon United States	22	591 1.2×	765 2.0×	260 0.8×	510 2.8×	299 2.3×	46	1.7k
ZoAnn E. Dreyer United States	21	898 1.9×	248 0.7×	208 0.6×	633 3.5×	230 1.8×	58	1.6k
Linda C. Stork United States	23	603 1.3×	436 1.2×	153 0.5×	754 4.2×	294 2.2×	72	1.5k
Rochelle Yanofsky Canada	22	793 1.7×	174 0.5×	91 0.3×	417 2.3×	181 1.4×	46	1.4k
Birgitta Versluys Netherlands	22	501 1.1×	423 1.1×	121 0.4×	487 2.7×	381 2.9×	83	1.6k
Benedetta Contoli Italy	11	116 0.2×	205 0.5×	258 0.8×	140 0.8×	52 0.4×	31	756
Karin Mellgren Sweden	19	180 0.4×	217 0.6×	65 0.2×	152 0.8×	177 1.4×	69	889
Inken Hilgendorf Germany	22	281 0.6×	648 1.7×	117 0.3×	201 1.1×	408 3.1×	89	1.4k

Countries citing papers authored by Ann E. Haight

Since Specialization

Citations

This map shows the geographic impact of Ann E. Haight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann E. Haight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann E. Haight more than expected).

Fields of papers citing papers by Ann E. Haight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann E. Haight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann E. Haight. The network helps show where Ann E. Haight may publish in the future.

Co-authorship network of co-authors of Ann E. Haight

This figure shows the co-authorship network connecting the top 25 collaborators of Ann E. Haight. A scholar is included among the top collaborators of Ann E. Haight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann E. Haight. Ann E. Haight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meacham, Lillian R., et al.. (2023). Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?. Transplantation and Cellular Therapy. 29(8). 531.e1–531.e4. 9 indexed citations

Stenger, Elizabeth, Benjamin Watkins, Kuang‐Yueh Chiang, et al.. (2023). Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure. Blood Advances. 7(10). 2196–2205. 12 indexed citations

Teherani, Mehgan, Shanmuganathan Chandrakasan, Ann E. Haight, et al.. (2023). Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 29(12). 778.e1–778.e6. 1 indexed citations

Schoettler, Michelle Long, Elizabeth Stenger, Ann E. Haight, et al.. (2022). Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children. Blood Advances. 7(9). 1784–1795. 9 indexed citations

Lai, Kristina, et al.. (2022). Comparison of Anti-Mullerian Hormone Levels Pre- and Post-Hematopoietic Cell Transplantation in Pediatric and Adolescent Females with Sickle Cell Disease. Transplantation and Cellular Therapy. 28(11). 770.e1–770.e6. 10 indexed citations

Stenger, Elizabeth, Diana Ross, Lillian R. Meacham, et al.. (2017). Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation. Blood. 130. 1999–1999. 1 indexed citations

Chaudhury, Sonali, Mouhab Ayas, Suhag Parikh, et al.. (2017). A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for β-Thalassemia. Biology of Blood and Marrow Transplantation. 23(10). 1695–1700. 14 indexed citations

Ross, Diana, et al.. (2017). Experiences and Decision Making in Hematopoietic Stem Cell Transplant in Sickle Cell Disease: Patients' and Caregivers' Perspectives. Biology of Blood and Marrow Transplantation. 24(5). 1041–1048. 36 indexed citations

Sano, Hirozumi, Kristy Applegate, Kuang‐Yueh Chiang, et al.. (2016). African American Race Is a Newly Identified Risk Factor for Postengraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 23(2). 357–360. 10 indexed citations

10.

Nanda, Ronica H., Chao Zhang, Sungjin Kim, et al.. (2015). Factors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation-Based Myeloablative Conditioning. International Journal of Radiation Oncology*Biology*Physics. 94(2). 349–359. 36 indexed citations

11.

Stenger, Elizabeth, Kuang‐Yueh Chiang, Ann E. Haight, et al.. (2015). Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases. Biology of Blood and Marrow Transplantation. 21(10). 1845–1852. 4 indexed citations

12.

Horan, John, Ann E. Haight, R. Clark Brown, et al.. (2015). Using Fludarabine to Reduce Exposure to Alkylating Agents in Children with Sickle Cell Disease Receiving Busulfan, Cyclophosphamide, and Antithymocyte Globulin Transplant Conditioning: Results of a Dose De-Escalation Trial. Biology of Blood and Marrow Transplantation. 21(5). 900–905. 24 indexed citations

13.

Haight, Ann E., et al.. (2012). Pneumatosis Intestinalis in Pediatric Hematopoietic Stem Cell Transplantation Patients: An Uncommon Complication. Fetal and Pediatric Pathology. 31(5). 309–314. 4 indexed citations

14.

Qayed, Muna, Kuang‐Yueh Chiang, Richard R. Ricketts, et al.. (2011). Tandem stem cell rescue as consolidation therapy for high‐risk neuroblastoma. Pediatric Blood & Cancer. 58(3). 448–452. 12 indexed citations

15.

McPherson, Marianne E., et al.. (2010). Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease. Bone Marrow Transplantation. 46(1). 27–33. 49 indexed citations

16.

Qayed, Muna, Kristy Applegate, Ann E. Haight, et al.. (2010). Is the updated Schwartz formula appropriate for assessing renal function prior to hematopoietic stem cell transplantation?. Pediatric Blood & Cancer. 55(1). 199–201. 10 indexed citations

17.

McPherson, Marianne E., et al.. (2009). Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor. Transfusion. 49(9). 1977–1986. 21 indexed citations

18.

Hillyer, Christopher D., et al.. (2007). CD36 immunization in a patient undergoing hematopoietic stem cell transplantation. Pediatric Blood & Cancer. 50(3). 660–662. 3 indexed citations

19.

Gow, Kenneth W., Mark L. Wulkan, Kurt F. Heiss, et al.. (2006). Extracorporeal membrane oxygenation for support of children after hematopoietic stem cell transplantation: the Extracorporeal Life Support Organization experience. Journal of Pediatric Surgery. 41(4). 662–667. 49 indexed citations

20.

Haight, Ann E., et al.. (2003). Nephrotoxicity of Iopamidol in Pediatric, Adolescent, and Young Adult Patients Who Have Undergone Allogeneic Bone Marrow Transplantation. Radiology. 226(2). 399–404. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact